Rezultati - Gauri Varadhachary
- Showing 1 - 9 results of 9
-
1
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018 od Jonathan M. Loree, Seerat Anand, Arvind Dasari, Joseph M. Unger, Anirudh Gothwal, Lee M. Ellis, Gauri Varadhachary, Scott Kopetz, Michael J. Overman, Kanwal Raghav
Izdano 2019Artigo -
2
Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline <i>BRCA</i> Variants od Milind Javle, Einat Shacham‐Shmueli, Lianchun Xiao, Gauri Varadhachary, Naama Halpern, David R. Fogelman, Ben Boursi, Syeda Uruba, Ofer Margalit, Robert A. Wolff, Talia Golan
Izdano 2021Artigo -
3
Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies od Milind Javle, Rachna T. Shroff, Henry Xiong, Gauri Varadhachary, David R. Fogelman, Shrikanth A.G. Reddy, Darren W. Davis, Yujian Zhang, Robert A. Wolff, James L. Abbruzzese
Izdano 2010Artigo -
4
Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy od Ching-Wei D. Tzeng, Jason B. Fleming, Jeffrey E. Lee, Xuemei Wang, Peter W. T. Pisters, Jean‐Nicolas Vauthey, Gauri Varadhachary, Robert A. Wolff, Matthew H. G. Katz
Izdano 2012Artigo -
5
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators od Matthew H. G. Katz, Jason B. Fleming, Priya Bhosale, Gauri Varadhachary, Jeffrey E. Lee, Robert A. Wolff, Huamin Wang, James L. Abbruzzese, Peter W. T. Pisters, Jean‐Nicolas Vauthey, Chusilp Charnsangavej, Eric P. Tamm, Christopher H. Crane, Aparna Balachandran
Izdano 2012Artigo -
6
Radiographic Tumor–Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer od Hop S. Tran Cao, Alpana Balachandran, Huamin Wang, Christina E. Bailey, Jeffrey E. Lee, Peter W. T. Pisters, Douglas B. Evans, Gauri Varadhachary, Christopher H. Crane, Thomas A. Aloia, Jean‐Nicolas Vauthey, Jason B. Fleming, Matthew H. G. Katz, Graciela M. Nogueras‐González
Izdano 2013Artigo -
7
Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma od Matthew H. G. Katz, Huamin Wang, Jason B. Fleming, Charlotte C. Sun, Rosa F. Hwang, Robert A. Wolff, Gauri Varadhachary, James L. Abbruzzese, Christopher H. Crane, Sunil Krishnan, Jean‐Nicolas Vauthey, Eddie K. Abdalla, Jeffrey E. Lee, Peter W. T. Pisters, Douglas B. Evans
Izdano 2009Artigo -
8
Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes od F Anthony San Lucas, Kelvin Allenson, Vincent Bernard, J. Castillo, D.U. Kim, Katherine Elizabeth Sleigh Ellis, Erik A. Ehli, Gareth E. Davies, Jason L. Petersen, D. Li, Robert A. Wolff, Matthew H. G. Katz, Gauri Varadhachary, Ignacio I. Wistuba, Anirban Maitra, Héctor M. Álvarez
Izdano 2015Artigo -
9
4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic Cancer od Donastas Sakellariou-Thompson, Marie-Andrée Forget, Caitlin Creasy, Vincent Bernard, Li Zhao, Young Uk Kim, Mark W. Hurd, Naohiro Uraoka, Edwin R. Parra, Ya’an Kang, Christopher A. Bristow, Jaime Rodriguez‐Canales, Jason B. Fleming, Gauri Varadhachary, Milind Javle, Michael J. Overman, Hector A. Alvarez, Timothy P. Heffernan, Jianhua Zhang, Patrick Hwu, Anirban Maitra, Cara Haymaker, Chantale Bernatchez
Izdano 2017Artigo
Iskalna orodja:
Sorodne teme
Internal medicine
Medicine
Cancer
Pancreatic cancer
Biology
Cancer research
Environmental health
Population
Surgery
Adenocarcinoma
Biochemistry
Breast cancer
Chemotherapy
Gene
Genetics
Neoadjuvant therapy
Oncology
Pancreatectomy
Pancreaticoduodenectomy
Radiology
Resection
Adjuvant therapy
Anthropology
Antigen
Asymptomatic
BRCA mutation
CD8
Cancer immunotherapy
Clinical endpoint
Clinical trial